Range of suitable people: CDEC talked over the uncertainty in the volume of patients with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're classified as having mild or average sickness may have a significant bleeding phenotype, wh